Policy & Advocacy MassBio Statement on President Trump’s executive order on drug pricing Apr 16, 2025
Policy & Advocacy Statement on CMS listing 15 additional drugs subject to price negotiations Jan 17, 2025
Policy & Advocacy Post-Election Healthcare and Biotech Outlook: Implications for Massachusetts and Beyond Dec 05, 2024
Thought Leadership Join Us at the MassBio 2024 Patient Advocacy Summit: Unifying through Storytelling Nov 04, 2024
Announcements MassBio Unveils Vision 2030, Strategic Roadmap to Propel Massachusetts’ Life Sciences Ecosystem Into Next Decade Oct 02, 2024
Announcements MassBio Statement on CMS’s Release of Prices for the First Ten Drugs Subject to the IRA’s Medicare Drug Price Negotiation Program Aug 15, 2024
